Percutaneous Access Device Seal for CNS Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current percutaneous devices face challenges in maintaining infection prevention and facilitating repeated access for therapeutic agent delivery to the central nervous system, particularly due to the risk of bacterial ingress and the need for repeated surgeries to administer treatments.

Innovation Solution

A percutaneous access device with a body having extracorporeal and subcutaneous surfaces, featuring ports that connect to implanted intracranial catheters, is designed with a seal to prevent microbial ingress and includes a flange to stabilize the device, encouraging fibrosis for integration and reducing movement, along with a delivery unit for controlled fluid administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a percutaneous access device is provided to allow repeated delivery of therapeutic agents, then the need for repeated surgery is eliminated, but the risk of bacterial ingress and infection increases

Engineering Contradiction:
Improverepeated access for therapy deliveryVSAvoidbacterial ingress risk
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a percutaneous access device that acts as an intermediary between the external environment and the intracranial catheter. The device includes a port system with seals and barriers that mediate the connection, allowing therapeutic agent delivery while preventing bacterial ingress. The access device serves as a protective interface that enables repeated access without direct skin penetration for each treatment session.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs disposable components such as seals and barriers that are replaced periodically to maintain infection prevention. These short-living components are designed to be replaced during routine access procedures, ensuring continuous protection against bacterial ingress while allowing repeated therapeutic access. The disposable nature of these components eliminates the need for complex sterilization protocols.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If a seal is provided between the port lumen and extracorporeal surface to prevent infection, then bacterial ingress is reduced, but access for therapeutic delivery becomes more complex

Engineering Contradiction:
Improveinfection preventionVSAvoidport seal structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The percutaneous access device is segmented into distinct functional components: a port system, seal elements, barrier components, and connection interfaces. This segmentation allows each component to be optimized independently for its specific function while maintaining overall simplicity. The modular design enables straightforward assembly and maintenance, reducing the practical complexity despite the multiple functional requirements.

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If multiple ports are provided for simultaneous or sequential administration through different catheters, then tailored treatment strategies are enabled, but device complexity increases

Engineering Contradiction:
Improvemultiple treatment optionsVSAvoidnumber of ports
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The percutaneous access device incorporates multiple ports that can serve different functions simultaneously or sequentially. Each port is designed with universal connection characteristics that allow compatibility with various catheter types and delivery systems. This multi-functionality enables tailored treatment strategies through different administration routes while maintaining a standardized device architecture that limits overall complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11717663B2Neurological apparatus comprising a percutaneous access device
Publication Date: 2023.08.08 RENISHAW (IRELAND) LTD
  • US11717663B2 patent drawing
  • US11717663B2 patent drawing
  • US11717663B2 patent drawing

AI summary

Apparatus for delivering therapeutic agents to the central nervous system of a subject is described. The apparatus includes at least one intracranial catheter and a percutaneous access device. The percutaneous access device includes a body having at least one extracorporeal surface and at least one subcutaneous surface, the body defining at least one port for connection to an implanted intracranial catheter. The port is accessible from the extracorporeal surface of the device, but is provided with a seal such as a rubber bung between the lumen of the port and the extracorporeal surface. The percutaneous access device may have more than two ports and/or a flange. A method of implanting the percutaneous access device is also described.